Text-message Reminders to Increase Rates of Postpartum Diabetes Screening in Women With Gestational Diabetes

NCT02013557 | Terminated DMC

• 1 other identifier: Pro00015015
• Study Type: interventional
• Target: 57
• Locations: 1 country
• Sites: 1

Brief Summary

Purpose: The purpose of this study is to see whether a text-message reminder system will increase the number of women who complete their diabetes screening after delivery. Study Design: Prospective randomized control trial Hypothesis: Gestational diabetics will be significantly more likely to follow up with their postpartum screening for diabetes if they receive text-message reminders to set up their lab appointment compared to those who receive usual care.

Conditions

Diabetes, Gestational

Keywords

Gestational Diabetes; Postpartum screening; Text-messages; 75-g oral glucose tolerance test

Outcome Measures

Primary Outcomes (1)

• Percentage of patients that receive the 2-hour 75-g oral glucose tolerance test

  Within six months of their delivery date

Secondary Outcomes (1)

• Percentage of patients that receive any type of postpartum diabetes screening

  Within six months of their delivery date

Study Arms (2)

Intervention Group

EXPERIMENTAL

Women in the intervention group will receive a test text-message reminder at the time of enrollment. They will then receive a text-reminder to schedule their oral glucose tolerance test at 6 weeks postpartum, with further reminders at 3 months and 6 months if they have not completed their testing.

Behavioral: Text-message reminder

Control group

NO INTERVENTION

This arm will only receive the test text-message reminder at the time of enrollment. Otherwise they will receive usual postpartum care.

Interventions

Text-message reminder BEHAVIORAL

Intervention Group

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Women diagnosed with gestational diabetes (GDM) based on a 100-g, 3-hour glucose tolerance test with 2 or more abnormal values according to the Carpenter-Coustan criteria OR Women with a 50-g, 1-hour loading test \>200mg/dl.
• Diagnosed with GDM at least at 24 weeks gestation or later
• Access to a personal mobile phone with text-messaging capabilities.
• Age 18 or greater
• Able to provide written and informed consent in English or Spanish language

You may not qualify if:

• Women that were ever diagnosed with diabetes outside of pregnancy.

Sponsors & Collaborators

• University of South Florida: lead

Study Sites (1)

Tampa General Hospital

Tampa, Florida, 33606, United States

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy Complications; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Judette Louis, MD

  University of South Florida Department of Obstetrics and Gynecology

  PRINCIPAL INVESTIGATOR

• Angela Gonzalez, MD

  University of South Florida Department of Obstetrics and Gynecology

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SCREENING
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 11, 2013
• First Posted: December 17, 2013
• Study Start: January 1, 2014
• Primary Completion: December 1, 2015
• Study Completion: December 1, 2015
• Last Updated: January 6, 2016

Record last verified: 2016-01

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)